Literature DB >> 18245647

Monitoring treatment of chronic myeloid leukemia.

Michele Baccarani, Fabrizio Pane, Giuseppe Saglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18245647     DOI： 10.3324/haematol.12588

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  How I monitor residual disease in chronic myeloid leukemia.

Authors:  Jerald P Radich
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

2.  Initial treatment for patients with chronic myeloid leukemia.

Authors:  M Baccarani
Journal:  Leuk Suppl       Date:  2012-08-09

3.  Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.

Authors:  Tatsuo Furukawa; Miwako Narita; Tadashi Koike; Kazue Takai; Koichi Nagai; Masashi Kobayashi; Satoru Koyama; Yoshinobu Seki; Hoyu Takahashi; Masahiro Fujiwara; Kenji Kishi; Koji Nikkuni; Noriatsu Isahai; Wataru Higuchi; Nobuhiko Nomoto; Souichi Maruyama; Masayoshi Masuko; Takashi Kuroha; Takashi Abe; Ken Toba; Masuhiro Takahashi; Yoshifusa Aizawa; Akira Shibata
Journal:  Int J Hematol       Date:  2011-02-05       Impact factor: 2.490

4.  Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib.

Authors:  Massimo Breccia; Giuliana Alimena
Journal:  Onco Targets Ther       Date:  2008-10-01       Impact factor: 4.147

5.  Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.

Authors:  Dan Jones; Suzanne Kamel-Reid; David Bahler; Henry Dong; Kojo Elenitoba-Johnson; Richard Press; Neil Quigley; Paul Rothberg; Dan Sabath; David Viswanatha; Karen Weck; James Zehnder
Journal:  J Mol Diagn       Date:  2008-12-18       Impact factor: 5.568

6.  Follow-up of the tumor load in patients with de novo chronic myeloid leukemia and in complete cytogenetic remission treated with imatinib in Colombia.

Authors:  Gonzalo Guevara; Jaime A González; Diego E Lopera; Manuel González; José D Saavedra; José Fernando Lobaton; Jorge Enrique Duque
Journal:  Colomb Med (Cali)       Date:  2012-12-30

7.  Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

Authors:  Michele Baccarani; Elisabetta Abruzzese; Vincenzo Accurso; Francesco Albano; Mario Annunziata; Sara Barulli; Germana Beltrami; Micaela Bergamaschi; Gianni Binotto; Monica Bocchia; Giovanni Caocci; Isabella Capodanno; Francesco Cavazzini; Michele Cedrone; Marco Cerrano; Monica Crugnola; Mariella D'Adda; Chiara Elena; Carmen Fava; Paola Fazi; Claudio Fozza; Sara Galimberti; Valentina Giai; Antonella Gozzini; Gabriele Gugliotta; Alessandra Iurlo; Gaetano La Barba; Luciano Levato; Alessandro Lucchesi; Luigia Luciano; Francesca Lunghi; Monia Lunghi; Michele Malagola; Roberto Marasca; Bruno Martino; Angela Melpignano; Maria Cristina Miggiano; Enrico Montefusco; Caterina Musolino; Fausto Palmieri; Patrizia Pregno; Davide Rapezzi; Giovanna Rege-Cambrin; Serena Rupoli; Marzia Salvucci; Rosaria Sancetta; Simona Sica; Raffaele Spadano; Fabio Stagno; Mario Tiribelli; Simona Tomassetti; Elena Trabacchi; Massimiliano Bonifacio; Massimo Breccia; Fausto Castagnetti; Fabrizio Pane; Domenico Russo; Giuseppe Saglio; Simona Soverini; Paolo Vigneri; Gianantonio Rosti
Journal:  Blood Adv       Date:  2019-12-23

8.  Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?

Authors:  Richard T Silver
Journal:  Oncologist       Date:  2011-03-30

Review 9.  Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

Authors:  Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 10.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Authors:  Michele Baccarani; Michael W Deininger; Gianantonio Rosti; Andreas Hochhaus; Simona Soverini; Jane F Apperley; Francisco Cervantes; Richard E Clark; Jorge E Cortes; François Guilhot; Henrik Hjorth-Hansen; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Richard A Larson; Jeffrey H Lipton; François-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Fabrizio Pane; Jerald P Radich; Philippe Rousselot; Giuseppe Saglio; Susanne Saußele; Charles Schiffer; Richard Silver; Bengt Simonsson; Juan-Luis Steegmann; John M Goldman; Rüdiger Hehlmann
Journal:  Blood       Date:  2013-06-26       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.